NEU 0.46% $19.30 neuren pharmaceuticals limited

Acadia, page-635

  1. 1,543 Posts.
    lightbulb Created with Sketch. 164
    Rightly or wrongly, I think "the market" is looking at the lower end of guidance due to the perceived disappointing Q1 sales, so I'm hoping for a surprise to the upside.
    Canadian approval is due mid-October, and if Acadia can replicate the US launch and get to market quickly, we should see a lift in the numbers for Q4 with sales in Nov and Dec.

    My uneducated guesstimate is:
    Q1: 75.9
    Q2: 92.5 (21.9%)
    Q3: 97.1 (5.0%)
    Q4: 126.0 (29.7%)
    Total: 391.5~ USD
    Last edited by mjc159: 08/07/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.